Endothelial function or dysfunction is a special interest of...

Endothelial function or dysfunction is a special interest of Sinclair. He has 11 publications around this issue as "vascular aging", "cognitive function", and "cardiovascular diseases". but not a single one how the product ATH434 of his company works on endothelial cells. Kosman has 10 "endothelial" papers and all of them relate to the brain its endothelial cells. Now Kosman has the only ATH434 paper on endothelial cells.

As we know ATH has been a "neurodegeneration company" but the biggest owner is interested more generally in vascular diseases as to how atherosclerosis starts. I would expect that Sinclair's ATH434 paper to be published one day. At that time ATH could broaden its scope from neurodegeneration to more general degeneration if the data would support it as I would think.

So it is now almost clear that ATH will not perhaps publish this Kosman's paper at this time. Perhaps ATH is waiting for something. What could be the reason not to publish this paper ???. I am ready to wait for a month if the waiting will result in a Sinclair paper about ATH434 and endothelial cells.